Csequence Insights
Stay Informed and Educated with Csequence’s Blog
Raelina Krikston: Creative Intelligence for the Cannabis Market
Raelina Krikston uses her talents to create educational material for consumers. Her understanding of the changing climate within the cannabis industry makes her a key visionary on the Csequence team.
Csequence: The Must-have Video Library for those Who Want to Stay Informed on the Science and Value of Cannabis
Csequence: The Must-have Video Library for those Who Want to Stay Informed on the Science and Value of Cannabis
A Review of Cannabis Use and Mortality Risks: Implications and Findings from a UK Biobank Study
This article is important as it provides critical insights into the potential health risks associated with heavy cannabis use, particularly highlighting the increased cardiovascular disease (CVD) mortality risk among females. These findings underscore the need for gender-specific public health strategies and clinical guidelines to address the growing prevalence of cannabis use.
States Rake in Big Bucks, The Federal Governments Steps In and Changes in the Way We Play Ball
This week the Federal government addresses key issues related to testing and clinical research in cannabis. States see impressive revenues from legalization. The NCAA removes marijuana from its banned substances list. States generating big revenue from legalization...
The Hidden Dangers of Edible Cannabis: Analyzing Emergency Department Visits Among Older Adults Post-Legalization in Ontario
This article highlights the significant public health implications of cannabis legalization, particularly for older adults who are at increased risk of adverse effects from cannabis poisoning. By examining the rise in emergency department visits post-legalization, the study underscores the need for targeted safety measures and age-specific guidelines to protect this vulnerable population.
Impact of State Cannabis Legalization on Health Care Encounters Among Older Adults
The article “State Cannabis Legalization and Trends in Cannabis-Related Disorders in US Older Adults, 2017 to 2022” provides a comprehensive analysis of the impact of state-level cannabis legalization on the prevalence of cannabis-related health care encounters among Medicare beneficiaries aged 65 and older. Utilizing a robust dataset spanning five years, the authors effectively characterize how legalization for medical use and recreational use correlates with reported cannabis-related disorders.
Marijuana use the good, the bad, and the weird. The Fed opens public comments on rescheduling.
The federal government solicits public comment on rescheduling marijuana until July 22, 2024. Take a look at people are saying or submit a comment. A round up of studies looking at the benefits of medicinal marijuana and some of the concerns. Comparing the damage of...
The AMA weighs in, debunking the “stoner” stereotype, and the illegal marijuana market
A study out this week from the American Medical Association suggests that consumers use marijuana primarily for health issues. Two studies suggest that the old “stoner” stereotype may be inaccurate. An early phase test in mice suggests that terpenes may be more effective than morphine in pain management. Despite legalization ProPublica reports crime in illegal marijuana sales still flourishes.
Unveiling the Genetic Landscape of Cannabis Use Disorder and Its Implications
This article is crucial as it sheds light on the intricate genetic relationships between cannabis use disorder (CanUD) and other substance use traits, providing valuable insights into the underlying mechanisms of substance dependence. Understanding these genetic influences is essential for informing evidence-based interventions, policy decisions, and public health strategies aimed at mitigating the risks associated with cannabis use and promoting healthier outcomes for individuals and communities.
An Overview of the Reclassification of Marijuana
Today is all about reclassifying marijuana from a Schedule I to a Schedule III drug and the impact it may have or may not have in the U.S. We’ve included a perspective from the Washington D.C.’s The Hill, Kyle Jaeger at Marijuana Moment, the ACLU and our own scientist Dr. Vita Maziveyi.
Exploring Potential Cannabis Reclassification: Opening the Doors for Cannabis Research
On June 4th, 2024, the National Center for Complementary and Integrative Health (NCCIH), a branch of the National Institutes of Health (NIH), will convene a landmark open meeting aimed at unlocking the mysteries of cannabis. With a keen focus on the plant’s potential in pain management, this gathering promises to unite leading NIH-funded researchers in a collaborative quest. By delving into the roles of minor cannabinoids and terpenes found within marijuana, experts seek to pioneer innovative solutions to one of healthcare’s most urgent challenges: effective pain relief.
Understanding the Dynamics of Tobacco and Cannabis Use During Pregnancy: Insights from the PATH Study
Understanding patterns of tobacco and cannabis use during pregnancy is crucial for safeguarding maternal and fetal health. The PATH study provides valuable insights into the prevalence of co-use before, during, and after pregnancy, highlighting the need for targeted interventions to support pregnant women in reducing substance use and protecting against adverse outcomes.